Global Ophthalmic Drugs Market (Treatment, type, geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast 2013-2020)

Category : Pharmaceuticals
enquire Customize Report

Ophthalmic drugs are the drugs that are used for the treatment of eye diseases and disorders. The ophthalmic drugs market is growing due to increase in prevalence of eye disorders and the use of combination therapies. Combination therapies have various advantages over traditional medication such as improved patient compliance and efficacy. 

The drivers that support the growth of ophthalmic drug market are aging population, changing lifestyle, technological changes, and increase in healthcare spending. Lack of awareness among people regarding eye diseases and disorders, absence of health insurance in developing countries are some of the challenges faced by the ophthalmic drugs market.

Ophthalmic drug Market analysis by Treatment:

The market is segmented into Dry eye drugs, Retinal drugs, Anti-inflammatory/allergy/infective drugs, Anti-glaucoma drugs. Glaucoma has the largest market share in the ophthalmic drugs market.

Ophthalmic drug Market analysis by Type

Ophthalmic drug type market is segmented into Prescription drugs and OTC drugs.OTC drugs for ocular allergy and dry eye is rapidly growing.

Ophthalmic drug Market analysis by geography

Geographically, ophthalmic drug market is segmented into North America (US), Europe (Germany, UK, and France), Asia Pacific (Japan, India, and China), and LAMEA. North America has the largest ophthalmic drugs market. Asia is the fastest growing ophthalmic drugs market.

Competitive landscape

Key players in the market focus on product launch, research & new product development, and mergers & acquisition. Product launch, with new combination therapies is the most important strategy adopted by major players in market. Novartis (ALCON), Allergan, Santen, Pfizer, Merck and Roche are the major players in the global ophthalmic drugs market. ALCON launched ILEVRO Suspension used to reduce pain and inflammation resulting from cataract surgery.

High Level Analysis

Porter’s five forces model reveals that bargaining power of supplier is less due to low switching cost and bargaining power of buyers is high due to availability of substitute products. Threat of substitute is high due to similarity in therapeutic functioning. Business strategies adopted by key players are analyzed. SWOT analysis helps in understanding the internal and external factors required for strategic business planning. 


This report analyses the factors that are driving and limiting the growth of the market
Market estimations are done according to the market trends for the period 2013-2018
Analysis of key strategies adopted by market players would assist in providing in-depth understanding of the market intelligence
In-depth analysis of segments such as targeted drug, type, and geography provides insights that would allow companies to gain competitive edge
Emphasis is laid on key factors affecting the growth of global ophthalmic drugs market. These factors are critically analyzed to reveal the most influencing factors in ophthalmic drugs market


The Ophthalmic drugs market is segmented based on Targeted drugs, Types and geography.


  • Dry eye Drugs
  • Retinal Drugs
  • Anti-inflammatory/Allergy/Infective Drugs
  • Anti-Glaucoma Drugs
  • Prescription Drugs
  • OTC Drugs


  • 1.North America 
    • U.S.
  • 2.Europe
    • Germany
    • UK
    • France
  • 3.Asia Pacific
    • Japan
    • India
    • China
  • 4.LAMEA
The Report is under production. Please fill in the form below to request for a TOC

* Marked Fields are Mandatory
Name * :
Email ID * :
Name of Company :
Country :
Phone No * :
Message :
Security code * :
Can't read the image? click here to refresh
Publisher Name : Allied Market Research

Published Reports
Insomnia - Current and Future Players Summary GlobalData has released its pharma report, “Insomnia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The report identifies and analyses ....
US $2995
Insomnia - 5EU Drug Forecast and Market Analysis to 2023 Summary Insomnia is the most common sleep disorder and is believed to affect approximately 35% of the global population. The condition can be defined as patient-reported difficultly with sleep initiation or sleep maintenance which can include ....
US $6995
Insomnia - Japan Drug Forecast and Market Analysis to 2023 Summary Insomnia is the most common sleep disorder and is believed to affect approximately 35% of the global population. The condition can be defined as patient-reported difficultly with sleep initiation or sleep maintenance which can include ....
US $4995

Upcoming Reports
Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others .
US $ 4148
Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) indicates APIs market gaining traction .
US $ 4148
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020
US $2850
Please Select Format
Single User : US $ 4148
Five User: US $ 5171
Enterprise User: US $ 7219
Data Pack :- US $ 3840

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.